Plunkett Research Online: Summit Therapeutics plc

SUMMIT THERAPEUTICS PLC (SMMT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule ant.....



Summit Therapeutics plc
Ticker: SMMT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 1235443939
Fax: 44 1235443999
Address: 2882 Sand Hill Road
Suite 106
Menlo Park, CA 94025 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description
Glyn EdwardsCEO/Chairman of the Board/Director
Manmeet SoniDirector
See More
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule ant.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (GBP)Bonus (GBP)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: